New York City-based NYU Langone Health recorded an operating income of $156.8 million (3.9% operating margin) in the third quarter of 2025, down from an operating gain of $161 million (4.4% margin) during the same quarter last year, according to its July 23 financial report.
Three things to know:
1. The system posted a total operating revenue of $4 billion for the three months ended May 31, up from $3.7 billion during the same period last year. Net patient service revenue totaled $3.1 billion, up from $2.9 billion. Pharmacy revenue totaled $320.3 million, up from $228.5 million.
2. Operating expenses totaled $3.9 billion in the third quarter of 2025, up from $3.5 billion during the same period last year. Salaries, wages and benefits totaled $2.4 billion, up from $2 billion. Supply and other expenses were $1.2 billion, up from $1.1 billion.
3. NYU Langone recorded a net income of $244 million in the quarter, down from a net income of $251.9 million during the same period last year.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
